204 related articles for article (PubMed ID: 2851893)
1. [Detection of pre-S gene products in HBsAg carriers and in hepatitis B vaccines].
Gerken G; Manns M; Kyriatsoulis A; Hess G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):374-9. PubMed ID: 2851893
[TBL] [Abstract][Full Text] [Related]
2. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
Theilmann L; Goeser T
Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133
[TBL] [Abstract][Full Text] [Related]
3. Polypeptides coded for by the region pre-S and gene S of hepatitis B virus DNA with the receptor for polymerized human serum albumin: expression on hepatitis B particles produced in the HBeAg or anti-HBe phase of hepatitis B virus infection.
Takahashi K; Kishimoto S; Ohnuma H; Machida A; Takai E; Tsuda F; Miyamoto H; Tanaka T; Matsushita K; Oda K
J Immunol; 1986 May; 136(9):3467-72. PubMed ID: 3007621
[TBL] [Abstract][Full Text] [Related]
4. Western blot analysis of the reactivity between envelope proteins of hepatitis B viruses from Brazilian carriers and antibodies raised against recombinant hepatitis B vaccines.
De Castro L; Yoshida CF; Gaspar AM; Gomes SA
Acta Virol; 1996; 40(5-6):251-8. PubMed ID: 9171452
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
Raz R; Koren R; Bass D
Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
[TBL] [Abstract][Full Text] [Related]
6. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
[TBL] [Abstract][Full Text] [Related]
7. An affordable multideterminant plasma-derived hepatitis B virus vaccine.
Prince AM; Vnek J; Brotman B
IARC Sci Publ; 1984; (63):355-72. PubMed ID: 6085626
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus infection by ELISA using a pre-S fusion protein expressed in E. coli.
Theilmann L; Burkhardt HD; Galle PR; Gmelin K; Kommerell B; Pfaff E
Arzneimittelforschung; 1988 Dec; 38(12):1856-8. PubMed ID: 3072959
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
10. A brief overview of the new vaccines against hepatitis B virus infection: immunogenic gene products and peptide analogues of antigenic epitopes.
Vyas GN
Dev Biol Stand; 1986; 63():141-6. PubMed ID: 2427376
[TBL] [Abstract][Full Text] [Related]
11. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
Romanò L; Biffi R; Bianchi S; Zanetti A
Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
[No Abstract] [Full Text] [Related]
12. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization.
Coursaget P; Adamowicz P; Bourdil C; Yvonnet B; Buisson Y; Barrès JL; Saliou P; Chiron JP; Mar ID
Vaccine; 1988 Aug; 6(4):357-61. PubMed ID: 2973189
[TBL] [Abstract][Full Text] [Related]
13. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
Tarocco RP; Faro G; Sargiotto A; Visconti C
Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
[TBL] [Abstract][Full Text] [Related]
16. [Humoral immunological response in laboratory animals after vaccination with recombinant vaccines against viral hepatitis B of different generations].
Górska P
Przegl Epidemiol; 2007; 61(2):393-400. PubMed ID: 17956059
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
18. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen.
Shinji T; Koide N; Hanafusa T; Hada H; Oka T; Takayama N; Shiraha H; Nakamura M; Ujike K; Yumoto Y; Tsuji T
Hepatogastroenterology; 1998; 45(20):500-2. PubMed ID: 9638436
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization.
Coursaget P; Buisson Y; Bourdil C; Yvonnet B; Molinié C; Diop MT; Chiron JP; Bao O; Diop-Mar I
Res Virol; 1990; 141(5):563-70. PubMed ID: 2148981
[TBL] [Abstract][Full Text] [Related]
20. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.
Xu ZY; Liu CB; Francis DP; Purcell RH; Gun ZL; Duan SC; Chen RJ; Margolis HS; Huang CH; Maynard JE
Pediatrics; 1985 Nov; 76(5):713-8. PubMed ID: 3903646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
